sorafenib has been researched along with o-(chloroacetylcarbamoyl)fumagillol in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (o-(chloroacetylcarbamoyl)fumagillol) | Trials (o-(chloroacetylcarbamoyl)fumagillol) | Recent Studies (post-2010) (o-(chloroacetylcarbamoyl)fumagillol) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 476 | 10 | 31 |
Protein | Taxonomy | sorafenib (IC50) | o-(chloroacetylcarbamoyl)fumagillol (IC50) |
---|---|---|---|
Methionine aminopeptidase 2 | Homo sapiens (human) | 0.593 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Luzzio, FA; Monsen, PJ | 1 |
1 other study(ies) available for sorafenib and o-(chloroacetylcarbamoyl)fumagillol
Article | Year |
---|---|
Antiangiogenic Activity and Chemical Derivatization of the Neurotoxic Acetogenin Annonacin Isolated from Asimina triloba.
Topics: Angiogenesis Inhibitors; Animals; Aorta, Thoracic; Asimina; Capillaries; Fruit; Furans; In Vitro Techniques; Lactones; Molecular Structure; Plant Extracts; Rats; Seeds; Structure-Activity Relationship | 2018 |